265 related articles for article (PubMed ID: 31060996)
1. Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer.
Bai SY; Ji R; Wei H; Guo QH; Yuan H; Chen ZF; Wang YP; Liu Z; Yang XY; Zhou YN
Turk J Gastroenterol; 2019 May; 30(5):415-419. PubMed ID: 31060996
[TBL] [Abstract][Full Text] [Related]
2. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer.
Jiang X; Jiang M; Xu M; Xu J; Li Y
Pathol Res Pract; 2019 May; 215(5):900-904. PubMed ID: 30732916
[TBL] [Abstract][Full Text] [Related]
3. Expression Levels of miR-127-3p and miR-144-3p in Gastric Cancer and their Relationships with Clinicopathological Parameters.
Sahami-Fard MH; Yazd EF; Jamalpoor Z; Nezhadi A
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538067
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
[TBL] [Abstract][Full Text] [Related]
5. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
6. Circulating serum exosomal
Lu X; Lu J; Wang S; Zhang Y; Ding Y; Shen X; Jing R; Ju S; Chen H; Cong H
Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
[No Abstract] [Full Text] [Related]
10. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer.
Guo Y; Cui X; Zhang Y; Ma X; Ren A; Huang H
Cancer Biother Radiopharm; 2023 Mar; 38(2):95-101. PubMed ID: 32898433
[No Abstract] [Full Text] [Related]
11. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
12. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
[TBL] [Abstract][Full Text] [Related]
14. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
[TBL] [Abstract][Full Text] [Related]
16. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer.
Yuan H; Chen Z; Bai S; Wei H; Wang Y; Ji R; Guo Q; Li Q; Ye Y; Wu J; Zhou Y; Qiao L
Cancer Lett; 2018 Apr; 418():84-96. PubMed ID: 29337109
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
[TBL] [Abstract][Full Text] [Related]
20. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
Li BS; Zhao YL; Guo G; Li W; Zhu ED; Luo X; Mao XH; Zou QM; Yu PW; Zuo QF; Li N; Tang B; Liu KY; Xiao B
PLoS One; 2012; 7(7):e41629. PubMed ID: 22860003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]